Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Paul D. Harker-Murray MD, PhD
Associate Professor
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
09/1989 - 05/1993 BS-Psychology, University of Michigan, Ann Arbor, MI
05/1993 - 05/2001 MD, Mayo Medical School, Mayo Clinic & Foundation, Rochester, MN
05/1993 - 05/2001 PhD, Mayo Graduate School, May Clinic & Foundation, Rochester, MN
2013 - 2014 Faculty Scholar Program in Quality & Safety, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/2001 - 06/2004 Internship and Residency in Pediatrics, Pediatrics, University of Minnesota, Children's Hospital Minneapolis, 2450 Riverside Avenue, Minneapolis, MN 55454
07/2004 - 09/2007 Postdoctoral Fellowship, Pediatrics, Hematology/Oncology/BMT, University of Minnesota, 2450 Riverside Avenue, 6th Floor, Minneapolis, MN 55454

FACULTY APPOINTMENTS:
11/01/2001 - 07/15/2013 Assistant Professor, Pediatrics, Hematology/Oncology/BMT, University of Texas, Southwestern Medical Center in Dallas, 1801 Inwood Road, Dallas, TX 75235
08/2013 - 06/2016 Assistant Professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, 8701 Watertown Plank Road, MFRC 3018, Milwaukee, WI 53226
07/2016 - Present Associate Professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2010 - 2013 Education Coordinator for Hematology, Oncology, Bone Marrow Transplant, Children's Medical Center, 1935 Medical Center Drive, Dallas, TX 75235
2015 - Present Director of Resident Education for Hematology, Pediatrics, Hematology/Oncology/Bone Marrow Transplant, Children's Hospital of Wisconsin, 9000 W Wisconsin Avenue, Milwaukee, WI 53226

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
2014 - Present Hospital Acquired Condition (HAC) leader. Invited position., Children's Hospital of Wisconsin, Milwaukee, WI
2014 - Present Value champion: Oversee all quality improvement initiatives, Hematology, Oncology, Bone Marrow Transplantation, Pediatrics, Milwaukee, WI
2014 - 2015 Leader: Clinical Documentation Improvement group of Operational and Financial Stewardship core team, Children's Hospital of Wisconsin, Milwaukee, WI
2014 - 2015 Operational and Financial Stewardship core team, Invited Member, Children's Hospital of Wisconsin, Milwaukee, WI
2017 - Present Epic Provider Clinical Documentation Improvement, Children's Hospital of Wisconsin, Milwaukee, WI 53226
2018 - Present Medical Director, Pediatrics, Hematology/Oncology/BMT Clinical Trials Office
2018 - Present EPIC Provider Cabinet GroupAd Hoc committee to make decisions regarding updates to the electronic medical record that affect multiple areas of care, Children's Hospital of Wisconsin

RESEARCH ADMINISTRATIVE APPOINTMENTS:
2016 - Present Institutional Principle Investigator for all Children's Oncology Group (COG) Clinical trials, Pediatrics, Hematology, Oncology, Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
12/04/2007 - 07/15/2013 Pediatrics, Hematology/Oncology/BMT, Children's Medical Center, 1935 Medical Center Drive, Dallas, TX 75235
12/04/2007 - 07/15/2013 Pediatrics, Hematology/Oncology/BMT, St. Paul University Hospital - UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235
12/04/2007 - 07/15/2013 Pediatrics, Hematology/Oncology/BMT, Parkland Health & Hospital System, 5201 Harry Hines Blvd, Dallas, TX 75235
08/01/2013 - Present Active, Pediatrics, Hematology/Oncology/BMT, Children's Hospital of Wisconsin, 9000 W. Wisconsin Avenue, Wauwatosa, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Pediatric Hematology/Oncology
2009
None
 
Licensure
Number Issue DateExpiration
Medicine and Surgery
61047-20
07/09/2013
10/31/2021
 

AWARDS AND HONORS:
1992 Gold Key Honor Society, University of Michigan
1992 David Bohr Research Fellowship Award
1999 Outstanding Young Leader Award, Zumbro Valley Medical Society
2000 Keynote Speaker at Gamehaven Council of the BSA Annual Eagle Recognition and Alumni Dinner, Boy Scouts of America
2000 Lyle Weed, MD Healthy Community Award, Olmstead County Public Health Services
2004 Susan Vincent Outstanding Resident Teaching Award
2010 Excellence in Education Medical Student Clinical Teaching Award, UT Southwestern
2011 Advocacy Mentor Award, UT Southwestern
2013 Dr. George Buchanan Teaching Award for Excellence in Fellow Education
2013 Faculty Teacher of the Year Award, Children's Medical Center Pediatric Residency
2014 Mobile App Challenge Winner
2018 MCW Cancer Center Outstanding Achievement Award in Pediatric Clinical Research, Medical College of Wisconsin Cancer Center

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Society of Clinical Oncology (Member)
Children's Oncology Group (Member)
American Society of Pediatric Hematology and Oncology (Member)
American Society of Hematology (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2014 - 2017 Young Investigator abstracts
2015 Clinical Research Associates
Journal Review
2013 - 2019 Journal of Pediatric Hematology and Oncology (2013, 2014, 2015, 2017, 2018, 2019 x6)
2014 Leukemia and Lymphoma
2015 - 2018 Pediatric Blood and Cancer (2015, 2016 x2, 2018 x2)
2017 Journal of Pulmonary Medicine

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2012 - Present Member, Children's Oncology Group Hodgkin Lymphoma Retrieval Subcommittee, Children's Oncology Group
2012 - Present Member, Children's Oncology Group Hodgkin Lymphoma Committee, Children's Oncology Group
2012 - Present Member, Children's Oncology Group Hodgkin Lymphoma Steering committee, Children's Oncology Group
2012 - Present Member, Children's Oncology Group Young Investigator Committee, Children's Oncology Group
2014 - Present One of 12 pediatric oncologist selected from a national pool, Epic Pediatric Oncology Steering Board
2014 - Present Member, Children's Oncology Group Langerhans Cell Histiocytosis Subcommittee of the Non-Hodgkin lymphoma committee, Children's Oncology Group
2015 - Present Course Co-chair, Board Review, American Society of Pediatric Hematology and Oncology
2016 - Present Appointed Member, Study Committee ANHL1522, Children’s Oncology Group
2016 - Present Invited by Daniel Hayes, MD, FASCO, President-Elect of ASCO to serve as member, Cancer Education Committee, Pediatric Oncology Track, American Society of Clinical Oncology (ASCO)
2016 - Present Member, Solution for Patient Safety (SPS) Hematology and Oncology CLABSI Reduction Workgroup, National collaboration among >30 Children's Hospitals
2017 - 2020 Elected Position, American Society of Pediatric Hematology and Oncology Nominating Committee, American Society of Pediatric Hematology and Oncology
2017 - Present liaison from the ASPHO Review Course Committee, American Society of Pediatric Hematology and Oncology (ASPHO) Education Committee, American Society of Pediatric Hematology and Oncology (ASPHO)
2017 - Present Chairperson, Epic Pediatric Oncology Steering Board, nominated and elected by colleagues on the steering board 2017. Lead team to develop improved functionality of EPIC

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
AHOD1721: Risk-adapted, response-based, Phase II open-label trial of nivolumab + brentuximab vendotin for children, adolescents, and young adults with relapsed/refractory (R/R) CD30 + classic Hodgkin lymphoma who have failed first-line therapy, followed by brentuximab + bendamustine for participants with a suboptimal response.
Source:
Children's Oncology Group and with international collaboration with EuroNET
Role:
Trial concept, design, and Principal Investigator
PI:
Paul Harker-Murray
Dates:
2012 - Present
 
Title:
Use of Computerized Physician Order Entry (CPOE) reduces provider chemotherapy errors in pediatric oncology center
Role:
Institutional Principle Investigator
PI:
Paul Harker-Murray, MD
Dates:
2012 - Present
 
Title:
Phase 1 Dose-escalating Study of MM-398 (Nanoliposomal Irinotecan) plus Intravenous Clycophosphamide in Recurrent or Refractory Pediatric Solid Tumors.
Source:
South Plains Oncology Consortium (SPOC)
Role:
Protocol Chairperson/Principle Investigator
Dates:
2012 - Present
 
Title:
ALTE11C1 - Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2014 - Present
 
Title:
ACCL0922 - A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2014 - Present
 
Title:
Phase II Brentuximab Vedotin or Crizotinib with Chemotherapy for Newly Diagnosed ALCL
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2014 - Present
 
Title:
COG-APEC14B1. The project everychild protocol: a registry, eligibility screening, biology and outcome study
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2016 - Present
 
Title:
ACCL1333/CV185155: A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated Asparaginase
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2016 - Present
 
Title:
Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults with CD20+ Mature B-Cell Lymphoma Protocol Type: Treatment
Role:
Institutional Principle Investigator
Dates:
2016 - Present
 
Title:
AOST1421 A Phase II Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038, IND# 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma
Source:
Children’s Oncology Group
Role:
Institutional Principle Investigator
Dates:
2016 - Present
 
Prior
Peer Review
Title:
Research on the effect of Ramipril on vascular activity, changes associated with atherosclerosis-induced diabetes in rabbits
Source:
University of Michigan Physiology Department
Role:
Laboratory Research
Dates:
05/1991 - 09/1991
 
Title:
Characterization of the role of endothelium in vascular activity in streptozotocin-induced diabetes in rats."
Source:
University of Michigan, Physiology Department
Role:
Laboratory Research
Dates:
09/1991
 
Title:
Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats.
Source:
University of Michigan, Physiology Department
Role:
Laboratory Research
Dates:
05/1992 - 09/1992
 
Title:
Comparing the insulin sensitizing agent CS-045 with angiotensin-converting enzyme inhibitor quinapril, on insulin resistance in spontaneously hypertensive rats.
Source:
Grant
Role:
Investigator
Dates:
09/1992 - 12/1992
 
Title:
Immune effectors of resistance to demyelination and neurologic disease in a viral model of multiple sclerosis.
Source:
Mayo Graduate School, Department of Immunology
Role:
Laboratory Research/Doctoral Thesis
Dates:
1995 - 2000
 
Title:
Evaluating the methodological quality of clinical practice guidelines for the treatment of patients with diabetes mellitus.
Source:
Mayo Clinic and Foundation Research, Department of Internal Medicine, Division of Endocrinology
Role:
Investigator
Dates:
10/2000
 
Title:
Developing novel methods of inducing human naive CD4+ T cells to differentiate into CD4+D25+FoxP3+ regulatory T cells and study of in vivo function of human regulatory T cell function.
Source:
Pediatric Hematology/Oncology and Blood and Bone Marrow Transplantation
Role:
Laboratory Research
Dates:
2005 - 2007
 
Title:
Open Label Bendamustine for Pediatric Patients with Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes.
Source:
Cephalon, Inc
Role:
Institutional Primary Investigator
PI:
Paul Harker-Murray, MD
Dates:
2011 - 2012
 
Title:
Randomized, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Decitabine as Epigenetic Priming with Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects.
Source:
Eisai
Role:
Institutional Principal Investigator
PI:
Paul Harker-Murray, MD
Dates:
2011 - 2012
 
Title:
An open-label, cross-over, pharmacokinetic study to assess the safety and pharmacokinetics of transdermal granisetron (SancusoR patch) and IV granisetron in a pediatric oncology population (aged 2 to 5 years).
Source:
Strakan Pharmaceuticals Ltd
Role:
Institutional Primary Investigator
PI:
Paul Harker-Murray, MD
Dates:
2012 - 2013
 
Title:
An open-label, cross-over, pharmacokinetic study to assess the safety and pharmacokinetics of transdermal granisetron (SancusoR patch) and IV granisetron in a pediatric oncology population (aged 6 to 12 years).
Source:
Strakan Pharmaceuticals Ltd
Role:
Institutional Primary Investigator
PI:
Primary Investigator
Dates:
2012 - 2013
 
Title:
Methylnaltrexone in Pediatric Populations: A Retrospective Chart Review. Supervising fourth year medical student, Stephanie Bezner.
Role:
Institutional Primary Investigator
PI:
Paul Harker-Murray, MD
Dates:
2012 - 2013
 
Title:
An open-label, cross-over, pharmacokinetic study to assess the safety and pharmacokinetics of transdermal granisetron (SancusoR patch) and IV granisetron in a pediatric oncology population (aged 13 to 17 years).
Source:
Strakan Pharmaceuticals Ltd
Role:
Institutional Primary Investigator
Dates:
2014 - Present
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Pesenter: Harker-Murray, Paul, Bandyopadhyay, S. et al, "Risk of serious bacterial infection in children with fever without a source in the post-haemophilus influenzae era when antibiotics are reserved for culture-proven bacteremia." Arch Pediatr Adolesc Med 2002; 156(5):512-517, University of Minnesota: Evidence-based Medicine Review, University of Minnesota, 2002
Harker-Murray, Paul, "A Brief Approach to Herbal Medical in the United States", University of Minnesota Department of Pediatrics Symposium on Complementary and Alternative Therapies, Minneapolis, MN, 2002
Harker-Murray, Paul, "Adherence of Published Diabetes Mellitus Practice Guidelines to Methodological Standards of Guideline Development, University of Minnesota, Pediatric Endocrinology, Minneapolis, MN, 2002
Harker-Murray, Paul, "Vaccine Safety", University of Minnesota, Department of Pediatrics, Minneapolis, MN, 2003
Harker-Murray, Paul, "Opportunities for Intervention in a Case of Acute Spinal Cord Injury", Hennepin County Medical Center, Department of Emergency Medicine Meeting, Minneapolis, MN, 2003
Harker-Murray, Paul, The Role of Hypertonic Saline in the Treatment of Elevated Intracranial Pressure, Department of Emergency Medicine Meeting at Hennepin County Medicine Center, Minneapolis, MN, 2003
Harker-Murray, Paul, "A Critical Review of Intravenous Methylprednisolone in Acute Spinal Cord Injury", Combined Department of Emergency Medicine Meetings - Hennepin County Medical Center and Regions Hospital, St. Paul, MN, 2003
Harker-Murray, Paul, "Pathology and Treatment of Acute Graft-Versus-Host Disease", Resident and Medical Staff Lectures, University of Minnesota Department of Pediatrics, Minneapolis, MN, 2004
Harker-Murray, Paul, "EBV+T Cell Posttransplant Lymphoproliferative Disorder in Children", "Pediatric Cancer and Blood Diseases Conference, University of Minnesota, Department of Pediatric Hematology and Oncology, Minneapolis, MN, 2004
Harker-Murray, Paul, "Hemoglobin Electrophoresis in the Diagnosis of Thalassemia", Residents and Medical Students Lectures, University of Minnesota, Minneapolis, MN, 2004
Harker-Murray, Paul, "Neonatal Thrombocytopenia", Resident and Medical Student Lectures, University of Minnesota, Minneapolis, MN, 2004
Harker-Murray, Paul, "Immune Reconstitution Following Bone Marrow Transplantation", Residents and Medical Students Lectures, University of Minnesota, Minneapolis, MN, 2004
Harker-Murray, Paul, "Meningitis in Bone Marrow Transplant Patients.", Pediatric Cancer and Blood Diseases Conference, University of Minnesota, Department of Pediatric Hematology and Oncology, Minneapolis, MN, 2005
Harker-Murray, Paul, "Poor Hematopoietic Recovery Following Induction Therapy for ALL." "Syndromes of Immunodeficiency and Macrophage Activation.", Pediatric and Blood Cancer Conference, University of Minnesota, Department of Pediatrics, Minneapolis, MN, 2005
Harker-Murray, Paul, "Nasopharyngeal Carcinoma in Pediatric Patients", Pediatric Cancer and Blood Diseases Conference, University of Minnesota, Department of Pediatrics, Minneapolis, MN, 2006
Harker-Murray, Paul, "Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Leukemia with and without CNS Involvement, 21st Annual Pediatric Research, Education, and Scholarship Symposium, Minneapolis, MN, 2007
Harker-Murray, Paul, "Metastatic Rhabdomyosarcoma", Pediatric Cancer and Blood Disease Conference, University of Minnesota, Department of Pediatrics, Minneapolis, MN, 2007
Harker-Murray, PH, Practical and Ethical Dilemmas in Cord Blood Banking, Practical Pediatric Hematology-Oncology 2008, Children's Medical Center in conjunction with UTSW Department of Pediatrics, Dallas, TX, 10/2008
Harker-Murray, PH, An Ethical Dilemma: A controversy in collecting umbilical cord blood for donation to a public bank, Pediatric Hematology/Oncology Grand Rounds, UT Southwestern, 02/2010
Harker-Murray, PH, Cord Blood Banking - Provider Responsibilities, UT Southwestern Maternal Fetal Medicine Lecture Series, UT Southwestern, 04/2011
Harker-Murray, PH, Umbilical Cord Blood Banking: a "safeguard for the future?", UT Southwestern Medical Center Pediatric Grand Rounds, Dallas, TX, 04/2012
Harker-Murray, PH, Practical Pediatric Hematology-Oncology 2008: Ethical Risks and Practical Benefits of Cord Blood Banking, Children's Medical Center in conjunction with UTSW Department of Pediatrics, Dallas, TX, 11/2012
Harker-Murray, PH, Hemophagocytic Lymphohistiocytosis, Multidisciplinary Case Conference, Children's Medical Center, Dallas, TX, 12/2012
Harker-Murray, PH, Fibrodysplasia Ossificans Progessiva, Multidisciplinary Case Conferences, Children's Medical Center, Dallas, TX, 01/2013
Harker-Murray, PH, Common Symptoms and Intern Calls in Oncology - Preparation for Internship, Medical Student Elective, Dallas, TX, 03/2013
Harker-Murray, PH, Pediatric Oncology: Introducing a family to childhood cancer, Dallas Chapter of the American Academy of Professional Coders, Dallas, TX, 03/2013
Toxic Epidermal Necrolysis in a child with Burkitt lymphoma, Multidisciplinary tumor board, Medical College of Wisconsin, Milwaukee, WI, 04/2014
Therapeutic options for low risk Wilms tumor, Multidisciplinary tumor board presentation, Medical College of Wisconsin, Milwaukee, WI, 05/2014
Checkpoint Inhibitors: Targetable pathways in pediatric Hodgkin and non-Hodgkin lymphomas, Multidisciplinary tumor board presentation, Medical College of Wisconsin, Milwaukee, WI, 08/2015
Checkpoint Inhibitors: Targetable pathways in pediatric Hodgkin and Non-Hodgkin lymphomas, Multidisciplinary Tumor Board Presentation, Medical College of Wisconsin, 08/2015
High risk Hodgkin Lymphoma in the Brentuximab Era, Multidisciplinary tumor board presentation, Medical College of Wisconsin, Milwaukee, WI, 09/2015
Methylnaltraxone for opioid induced constipation, Multidisciplinary tumor board presentation, Medical College of Wisconsin, Milwaukee, WI, 09/2015
 
Regional
Harker-Murray, PH, "What do YOU Think, Doctor, Should We Get It?" Antenatal Counseling on Stem Cell Cord Blood Collection, American College of Osteopathic Obstetricians and Gynecologists, Grapevine, TX, 10/2012
 
National
Harker-Murray, PH, Practical and Ethical Dilemmas in Cord Banking, 41st Kenneth C. Haltalin Pediatrics for the Practitioner Annual Seminar, 04/2009
Harker-Murray, PH, Pediatric Cancer - An Overview, The Southwest Center for Pediatric Environmental Health and Lake Country AHEC Conference on Children's Environmental Health, Paris, TX, 09/2009
Harker-Murray, PH, Review Course: Lymphoma, American Society of Pediatric Hematology and Oncology, 02/2011
Harker-Murray, PH, Practical Pediatric Hematology-Oncology 2011: Lymphadenopathy and Lymphoma, Children's Medical Center in conjunction with UTSW Department of Pediatrics, Dallas, TX, 11/2011
Harker-Murray, PH, The Efficacy of Umbilical Cord Stem Cells from Private and Public Cord Blood Banks: Present and Anticipated Future Clinical Utility, American College of Osteopathic Obstetricians and Gynecologists Meeting, Tucson, AZ, 03/2012
 
International
Relapsed Hodgkin Lymphoma in Children: “How do we best stratify intensity of retrieval therapy?”, Children’s Oncology Group bi-annual meeting, 2013
Brentuximab vedotin and bendamustine for relapsed pediatric Hodgkin lymphoma, Children’s Oncology Group bi-annual meeting. Fall, 2014
Relapsed Hodgkin Lymphoma in Children: Proposal for a risk-stratified, response-based trial, Children’s Oncology Group bi-annual meeting. Spring, 2014
Nivolumab Followed by Chemotherapy for Relapsed Hodgkin Lymphoma in Children: Proposal for a risk-stratified, response-based trial., Children’s Oncology Group bi-annual meeting. Fall, 2015
Incorporation of a PD-1 inhibitor into a clinical trial for Relapsed Hodgkin Lymphoma in Children: Proposal for a risk-stratified, response-based trial., Children’s Oncology Group bi-annual meeting. Spring, 2015
Relapsed Hodgkin Lymphoma in Children: Proposal for a collaborative risk-stratified, response-based trial wiht COG and EuroNet., Children's Oncology Group B-Annual Meeting, 2016
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Lymphoma., American Society of Pediatric Hematology and Oncology Pediatric Hematology and Oncology Board Review Course, 02/2011
Hodgkin and Non-Hodgkin Lymphoma., American Society of Pediatric Hematology and Oncology Pediatric Hematology and Oncology Board Review Course, 02/2013
Lymphoma, American Society of Pediatric Hematology and Oncology Board Review Course, 02/2015
Lymphoma, American Society of Pediatric Hematology and Oncology Board Review Course, 02/2017
Lymphoma. American Society of Pediatric Hematology and Oncology Pediatric Hematology and Oncology Board Review Course, 02/2019
Clinical Conundrums in Relapsed Hodgkin Lymphoma: Presentation and interactive discussion on Relapsed Hodgkin Lymphoma at the American Society of Pediatric Hematology and Oncology Annual Meeting, 05/2019
 

COMMITTEE SERVICE:
Medical College
2008 - 2013 Member, Pediatric Residency Admissions Committee, Pediatrics, UT Southwestern
2010 - 2013 Officer, Billing Compliance, University of Texas Southwestern
2011 - 2013 Member, Fellowship Admissions Committed, Hematology/Oncology/BMT, Pediatrics, UT Southwestern
2012 - 2013 Member, Continuing Medical Education Committee, Pediatrics, University of Texas Southwestern
2012 - 2013 Physician Champion, Beacon Committee, Pediatrics, University of Texas Southwestern
2012 - 2013 Committee Member, Epic Implementation Committee, Pediatrics, University of Texas Southwestern
2012 - 2013 Oversight Physician, Clinical Research Office for the Center for Cancer and Blood Disorders, University of Texas Southwestern
2012 - 2013 Member, Chemotherapy Task Force, Pediatrics, University of Texas Southwestern
2013 - Present Member, Pediatric Intern Selection Committee, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
2013 - Present Co-chair, Hematology/Oncology/BMT Committee on Quality and Patient Saftey, Hematology/Oncology/BMT, Pediatrics, Children's Hospital of Wisconsin
2013 - Present Member, Faculty Scholar Program in Quality & Safety, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
2013 - Present Member, HOT Services Partnership Council, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
2013 - Present Member, Clinical Documentation Initiative to Improve Medical Communication, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
2013 - Present Member, Epic and Beacon Implementation, Pediatrics, Medical College of Wisconsin
2013 - Present Member, MACC Fund Design Core Team, Hematology/Oncology/BMT, Pediatrics, Medical College of Wisconsin
2014 - Present Member, Pediatric Hematology/Oncology Fellowship Admission Committee, Medical College of Wisconsin
2014 - Present Invited Member, Clinical Competency Committee for Pediatric Hematology Fellows, Medical College of Wisconsin
2014 Member, The Clinical Research Seed Grant Review Committee, Medical College of Wisconsin
 
Hospital
2013 - Present Member, Hematology/Oncology/BMT Services Partnership Council (Inpatient and Ambulatory QI and Clinical Practice, Hematology/Oncology/BMT, Pediatrics, Children's Hospital of Wisconsin
2013 - Present Member, Documentation Standards - Problem List Sub-committee, Hematology/Oncology/BMT, Pediatrics, Children's Hospital of Wisconsin
2013 - Present Participant/Member, Electronic Health Record Committee Sub-Group (to develop recommendations around medical staff documentation standards and problem list use and etiquette), Pediatrics, Medical College of Wisconsin
2013 - Present Member, Leukemia and Lymphoma Committee, Children's Hospital of Wisconsin
2014 - Present Member, Supportive Care & Cancer Control committee, Children's Hospital of Wisconsin
2014 - Present Member, Pharmacy & Therapeutics Committee, Children's Hospital of Wisconsin
2014 - Present Member, CLABSI subgroup of Solution for Patient Safety (SPS)
2014 - Present Member, Developmental Therapeutics committee, Children's Hospital of Wisconsin
2014 - Present Member, Catheter Line Associated Blood stream Infection (CLABSI) Safety Improvement Team, Children's Hospital of Wisconsin
2015 - Present Member, Septicemia Core Team, Children's Hospital of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Resident and Fellow Education
2013 - Present Ongoing Didactic Sessions for Residents and Fellows: Controlling Severe Pain In Hospitalized Children
2013 - Present Ongoing Didactic Sessions for Residents and Fellows: Hodgkin and Non-Hodgkin lymphoma
2013 - Present Ongoing Didactic Sessions for Residents and Fellows:E&M Coding in Pediatric Oncology.
2013 - Present Ongoing Didactic Sessions for Residents and Fellows: Lymphoma and lymphadenopathy
2013 - Present Ongoing Lectures to Residents and Fellows
 

EXTRAMURAL TEACHING:
Community/Lay Public
1999 - 2001 Rochester Public Library, Homework Assistance Study Table
1999 - 2001 Individual English Composition Tutor
2011 - 2013 West Mesquite High School, Mentor for GT Mentorship Program
 
Medical Student Education
2007 University of Minnesota Medical School, Group Instructor, Blood Course
2013 Dallas TX, Common Symptoms and Intern Calls in Oncology - Preparation for Internship, Medical Student Elective
 
Resident and Fellow Education
1996 - 2000 Mayo Graduate School, Dept of Immunology, Immunology Tutor
2004 Developed comprehensive study-guide for the Pediatric Licensure Examination based on guidelines from the American Academy of Pediatrics and the American Board of Pediatrics
2007 University of Minnesota Medical School, Tutor, Blood Course
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: Anatomic Approach to Bone Marrow Biopsies
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: Emergencies in Pediatric Oncology
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: Approach to Reading a Peripheral Blood Smear
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: Supportive Care in Pediatric Oncology
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: Introduction to Chemotherapy, Immunotherapy and Immunosuppression
2008 - 2013 UTSW, Didactic Session for Residents and Fellows: Pain Management in Oncology Patients
2008 - 2013 University of Texas Southwestern, Ongoing Didactic Sessions for Residents and Fellows: E&M Coding in Pediatric Oncology
2008 - 2013 University of Texas Southwestern, Ongoing and Didactic Sessions for Residents and Fellows: Hodgkin and Non-Hodgkin Lymphoma in Pediatric Oncology.
2010 - 2011 University of Texas Southwestern, Pediatric Residency Advocacy Project Mentor
2011 - 2013 University of Texas Southwestern, Pediatric Senior Resident Morning Report (small group case discussion with faculty)
2011 - 2013 University of Texas Southwestern, Pediatric Residency Mentor (oversee academic progress of six residents during training)
 
Continuing Medical Education
04/2009 41st Kenneth C. Haltalin Pediatrics for the Practitioner Annual Seminar, Practical and Ethical Dilemmas in Cord Banking
09/2009 The Southwest Center for Pediatric Environmental Health and Lake Country AHEC Conference on Children's Environmental Health, Paris, TX, Pediatric Cancer - An Overview
11/2011 Children's Medical Center in conjunction with UTSW Department of Pediatrics, Dallas, TX, Practical Pediatric Hematology-Oncology 2011: Lymphadenopathy and Lymphoma
11/2013 Children's Hospital of Wisconsin, Hodgkin Lymphoma in children. Oncology nursing lecture series lead by the leukemia and lymphoma group
03/2014 Children's Hospital of Wisconsin, Anaplastic Large Cell Lymphoma. Oncology nursing lecture series lead by the leukemia and lymphoma group
05/2014 Children's Hospital of Wisconsin, Pediatric Hodgkin lymphoma. Oncology nursing education series
05/2014 Children's Hospital of Wisconsin, Emergencies caused by lymphoma: Oncology nursing education series
07/2015 Children's Hospital of Wisconsin, Emergencies in Oncology: Didactic session for recently hired oncology nurses.
07/2015 Children's Hospital of Wisconsin, Pediatric Hodgkin and non-Hodgkin lymphoma: Didactic session for recently hired oncology nurses
07/2015 Children's Hospital of Wisconsin, Controlling Severe Pain In Hospitalized Children: Didactic session for recently hired oncology nurses
 
Graduate Student Education
1996 - 2000 Mayo Graduate School, Dept. of Immunology, Immunology Tutor
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Aaron Domak, Medical College of Wisconsin, 2013 - 2014 Clinical Apprenticeship Course Preceptor: Mentor
Medical College of Wisconsin, 2014 - 2015 Advisor, for medical student Hemal Patel, Clinical Advising Program
Victor Redmon, Medical College of Wisconsin, 2014 - Present Advisor for medical students in the Clinical Pathways in Quality Improvement and Patient Safety
Ashley Quinn, Medical College of Wisconsin, 2014 - Present Advisor for medical students in the Clinical Pathways in Quality Improvement and Patient Safety
Alexandra Lynch, Medical College of Wisconsin, 2014 - 2015 Clinical Apprenticeship Course Preceptor: Mentor
Sarah Kelm, Medical College of Wisconsin, 2015 - 2016 Present Clinical Apprenticeship Course Preceptor: Mentor
Rachael Henning, Medical College of Wisconsin, 2015 - Present Advisor for medical students in the Clinical Pathways in Quality Improvement and Patient Safety
 
Clinical/Research Fellows
Nathan Schloemer, Medical College of Wisconsin, 2013 - Present Mentor - Scholarly Activities Oversight
 
Residents
Lindsay Hoogenboom, MD, Medical College of Wisconsin, 2015 - Present Advisor
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Residents
University of Texas, Southwestern Medical Center, Dallas, 2010 - 2011 Pediatric Residency Advocacy Project Mentor
University of Texas, Southwestern Medical Center, Dallas, 2011 - 2013 Mentor, Pediatric Residency Program
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Resident
2010 - 2013 Developed and implemented comprehensive inpatient and outpatient education program for pediatric residents on the hematology and oncology service. Included recurring didactic sessions, teaching file
2015 - Present Developed and implement comprehensive inpatient education program for pediatric residents on hematology, oncology and bone marrow transplant
 
 
Clinical Programs
2013 Developed a comprehensive plan to improve efficiency and accuracy in documentation in EPIC that complied with provider E&M billing and coding and hospital APR-DRG based billing.
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Murray P. Pitt B. Webb RC. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia. 37(7):664-70, 1994 Jul.
2. Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. International Immunology 1996;8(1):131-41.
3. Rodriguez M, Rivera-Quinones C, Murray PD, Njenga MK, Wettstein PJ, Mak T. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. Journal of Neurovirology 1997;3(Suppl 1):S43-S45
4. Lin X, Pease LR, Murray PD, Rodriguez M. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. Journal of Immunology 1998;160(11):5661-8.
5. Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. Journal of Virology 1998;72(9):7320-9.
6. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. Journal of Neuroscience 1998;18(18):7306-14.
7. Murray PD, Njenga MK, McGavern DB, Lin X, Drescher KM, Rodriguez M. Absence of spontaneous central nervous system remyelination in Class II-deficient mice infected with Theiler's Virus. Journal of Neuropathology & Experimental Neurology 1999;58(1):78-91.
8. Drescher KM, Murray PD, David CS, Pease LP, Rodriguez M. CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathology 1999;9:21-31.
9. McGavern DB, Murray PD, Rodriguez M. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. Journal of Neuroscience Research 1999 58:492-504.
10. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000 123:519-531.
11. Drescher KM, Murray PD, David CS, Lin X, Carlino JA, and Rodriguez M. TGF2 reduces demyelination, limits virus antigen expression, and enhances apoptosis in a viral model of multiple sclerosis. Journal of Immunology 2000 164(6): 3207 - 3213
12. Murray PD, Wei T, Krivacic K, Chernosky A, and Rodriguez M, and Ransohoff RM. Bi-Phasic and regionally-restricted chemokine expression in the central nervous system in a Viral Model of Multiple Sclerosis. Journal of Neurovirology 2000(6) Suppl 1 S44-S52
13. Murray PD, Drescher KM, Leibowitz J, and Rodriguez M. Spontaneous oligodendrocyte-mediated remyelination is associated with improved neurologic function in a viral model of multiple sclerosis. Brain. 2001. 124(Pt 7):1403-16.
14. Murray PD, McGavern DB, Pease LR, Rodriguez M. Cellular sources and targets of IFN-mediated protection against viral demyelination and neurological deficits. European Journal of Immunology. 2002. 32:606-615.
15. Sica G, Harker-Murray PD, Montori VM, Smith SA, for the EVIDENS group. Adherence of Published Diabetes Mellitus Practice Guidelines to Methodological Standards of Guideline Development. Endocrinology and Metabolism Clinics of North America 2002. 31:819-828.
16. Crow SS, Sullivan VV, Aysola AE, Key NS, Harker-Murray PD, Foker JE, Steiner ME.Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. Ann Thorac Surg. 2007 Apr;83(4):1547-9.
17. Harker-Murray PD*, Lee AB*, Ferrieri P, Schleiss M, Tolar J. *Contributed equally. Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing. hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2008 Mar;50(3):673-6.
18. Harker-Murray PD, Avis J Thomas, MS, Xianghua Luo, PhD, Michael R Verneris, MD, Kathryn E Dusenbery, MD, Margaret L MacMillan, MD, Jakub Tolar, MD, PhD, K. Scott Baker, MD, MS, John E Wagner, MD and Paul J Orchard, MD. Allogenic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System. Biol Blood Marrow Transplant 2008; 14(6): 685-692.
19. Hippen KL, Harker-Murray PD., Porter SB et al Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood. 2008;112:2847-2857
20. Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M. Intraventricular Rituximab and Systemic Chemotherapy for Treatment of CNS PTLD after Kidney Transplantation Pediatr Transplant. 2012: 16: E201–E20
21. Amy C. Fowler, David Leonard, Tamra Slone, Christian Tellinghuisen, Paul Harker-Murray, Naomi Winick. Average Absolute Neutrophil Count During Maintenance Chemotherapy in Latino versus non-Latino Caucasian Patients with Childhood Acute Lymphoblastic Leukemia (Submitted)
22. Chris Fraser, Patrick Brown, Gail Megason, Hyo Seop Ahn, Bin Cho, Ivan Kirov, Lawrence Frankel, Richard Aplenc, Debra Bensen-Kennedy, Mihaela Munteanu, Jennifer Weaver, Paul Harker-Murray. Open Label Bendamustine for Pediatric Patients With Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes (In Press) J Pediatri Hematol Oncol. 2014 May; 36(4):e212-8
23. Harker-Murray P, Drachtman R, Hodgson D, Chauvenet A, Kelly K, Cole P, Stratification Treatment Intensity in Relapsed Pediatric Hodgkin Lymphoma, Pediatric Blood Cancer. 2013. Epub Journal of Pediatric Blood Cancer 8 Nov. 2013, DOI:10.1002/pbc.24851.
24. Emerging Immunotherapy in Pediatric Lymphoma Erker C, Harker-Murray P, Burke M. Future Oncol. 2016 Jan;12(2):257-70
 
Abstracts
1. Murray PD, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M. Perforin and Fas-mediated cytotoxic effector function in the development of demyelination and neurologic deficits in a viral model of multiple sclerosis. Platform Presentation: American Association of Neuropathologists Annual Meeting (June 1998), and Poster Presentation: 1998 Southern Minnesota Chapter of the Society for Neuroscience
2. Murray PD, Pavelko K, Leibowitz J, Pease LR, Rodriguez M. CD4+ and CD8+ T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. Poster Presentation: 1999 Southern Minnesota Chapter of the Society for Neuroscience
3. Murray PD, Drescher KM, Leibowitz J, and Rodriguez M. Extensive Myelin Repair in a Viral Model of Multiple Sclerosis. Poster Presentation: 1999 Experimental Biology (FASEB) April 1999, and Poster Presentation: 1999 Southern Minnesota Chapter of the Society for Neuroscience.
4. Murray PD, McGavern DB, Pease LR, Rodriguez M. Independent production of IFN by CD4 + and CD8+ T cells is required for resistance to viral persistence demyelination, and neurologic disease following infection with Theiler’s virus. Poster Presentation: June 1999, Gordon Research Conference on Neurovirology
5. Harker-Murray PD, Tolar J Tan Y, MacMillan ML Wagner JE, Orchard PJ. Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Isolated CNS Relapse. Poster Presentation. 2005 Annual Meeting of the American Society of Hematology. Abstract #2745 appears in Blood, Volume 106, issue 11, November 16, 2005
6. Harker-Murray PD, Dayton V, Neglia J, Tolar J Treatment of EBV-associated T cell post-transplant lymphoproliferative disorder with CNS involvement in a pediatric solid-organ transplant patient. 2006 ASCO Annual Meeting, Abstract No 9040.
7. Harker-Murray PD, Verneris MR, Thomas AJ, Luo X, MacMillan ML, Tolar J, Baker KS, Wagner JE, Orchard PJ. Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement. 2006 ASH Annual Meeting.
8. Pokala H, WeinbergA , Harker-Murray PD . The Management of Post-Transplant Lymphoproliferative Disorder Resembling Primary CNS Lymphoma in a Pediatric Renal Transplant Patient. 2010 ASPHO Annual Meeting
9. Gupta P, Harker-Murray PD, Sunitinib treatment of malignant pheochromocytoma in a pediatric patient. 2010 ASPHO Annual Meeting
10. Chris Fraser, Patrick Brown, Gail Megason, Hyo Seop Ahn, Bin Cho, Ivan Kirov, Lawrence Frankel, Richard Aplenc, Debra Bensen-Kennedy, Mihaela Munteanu, Jennifer Weaver, Paul Harker-Murray. Open Label Bendamustine for Pediatric Patients With Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes (2011 ASPHO Annual Meeting)
11. Christopher Henchen, Tiffany Morese, Rebecca Rehborg CCRT, Mary Kirby, Malini Shankar CCRP, Paul Harker Murray. Audit readay all the time: The digital clinical trials office. 2015 Children’s Oncology group Annual Meeting)
12. Lauren Ranallo, MSN, RN, AOCNS, CPHON, Carolyn Herda, BSN, RN, Gina Leonard, BSN, RN, Jody Orluske, BSN, RN, Kelly Pergande, BSN, RN, Paul Harker-Murray, MD, PhD 2016 National Association of Clinical Nurse Specialists Conference
13. Prevention of Central Line Associated Bloodstream Infections using Standard Bundles Varies by Patient Population (submitted to pediatric Academic Society Annual Meeting)
14. Craig Erker, Anna Huppler, Thomas J. Walsh, Neel Bhatt, Paul Harker-Murray. Conidiobolus Infection: Management during Induction Therapy for Acute Lymphoblastic Leukemia. American Society of Pediatric Hematology and Oncology Annual Meeting, 2016, Abstract 744.
15. Ashley Quinn BS1; Lauren Ranallo MSN, RN, AOCNS, CPHON; Alyse Bartczak BSN, RN; Paul Harker-Murray MD, PhD. Reducing CLABSIs in Pediatric Oncology Patients. Platform presentation. American College of Physicians, Wisconsin Chapter, 2016 Annual Meeting
 

jenkins-FCD Prod-398 336d56a365602aa89dcc112f077233607d6a5abc